Company intelligence / Profile preview

GreenTec

Saint-Beauzire, Puy-de-Dôme, France

Ownership: Private
Employees: ~201
Development stage: Other

Overview

GREENTECH has commercialized over 100 active ingredients and 5,000+ extracts, supplying cosmetic, pharmaceutical, and nutraceutical industries globally. All products undergo in vitro and in vivo testing; several APIs produced under GMP have exclusive pharma contracts.

Therapeutic areas: OtherDermatology
Modalities: Small moleculeBiologicMicrobial therapyPeptidesRecombinant proteinPlant-derived compound
Industry: Chemicals & Materials

Partnerships

Exclusive contracts with multiple pharmaceutical companies for extraction and purification of active molecules/API

Beyond the preview

Go deeper on GreenTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GreenTec.

Explore the full profile